Table 4– Pharmacological treatment of sarcoidosis-associated fatigue
Treatment categoriesSpecific agentsComments
Anti-inflammatory therapies for disease
 Antimalarial agentsHydroxychloroquineUse of agent associated with less fatigue [18]
 Anti-TNF monoclonal antibodiesInfliximabCase report and series [7, 48, 68]
AdalimumabCase series [7, 63]
NeurostimulantsMethylphenidateCase series [69]
d-MethylphenidateDouble-blind crossover trial [35]
ArmodafinilDouble-blind crossover trial [70]
  • TNF: tumour necrosis factor.